Abstract
This article describes p53 as a prognostic and predictive factor, together with some information on how best to determine the p53 status. By December 1998, 13,000 articles on p53 were identified on Pub Med, the National Library of Medicine. Within one week a further 62 articles were recorded making it difficult to give the complete p53 story. This review article will focus on discussing p53 in relation to its predictive potential. So far, no firm conclusions can be made based on the articles studied. This may be, in part, because many studies have used less than optimal techniques for determination of the p53 status, together with the fact that the studies lacked power to detect a potential difference in outcome from specific therapy in relation to p53 status.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adenocarcinoma / genetics
-
Adenocarcinoma / pathology
-
Adult
-
Aged
-
Amino Acid Substitution
-
Antineoplastic Agents / classification
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use
-
Antineoplastic Agents, Hormonal / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Apoptosis / drug effects
-
Apoptosis / radiation effects
-
Breast Neoplasms / drug therapy
-
Breast Neoplasms / genetics*
-
Breast Neoplasms / mortality
-
Breast Neoplasms / pathology
-
Breast Neoplasms / radiotherapy
-
Combined Modality Therapy
-
Estrogens
-
Female
-
Genes, erbB-2
-
Genes, p53*
-
Genes, ras
-
Humans
-
Middle Aged
-
Multigene Family
-
Neoplasm Proteins / analysis
-
Neoplasms, Hormone-Dependent / genetics
-
Neoplasms, Hormone-Dependent / pathology
-
Progesterone
-
Prognosis
-
Survival Analysis
-
Transfection
-
Treatment Outcome
-
Tumor Suppressor Protein p53 / analysis
Substances
-
Antineoplastic Agents
-
Antineoplastic Agents, Hormonal
-
Estrogens
-
Neoplasm Proteins
-
Tumor Suppressor Protein p53
-
Progesterone